← Leaderboards
Lee Marshall Nadler
Dana-Farber Cancer Inst
$396,612,225
Attributed
$396,612,225
Total exposure
40
Grants
34
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $55.6M · FY2005–25$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$500,082,598 · 43
By mechanism
UL1$410,635,934 · 23
UM1$32,472,010 · 1
U24$14,871,333 · 1
KL2$13,493,983 · 3
U19$10,654,029 · 3
P01$9,934,611 · 7
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Laurie H Glimcher$56,303,115
- Gregory Howard Bird$3,139,726
- James E Bradner$6,722,003
- Harold J. Burstein$2,344,755
- Birgit Knoechel$3,667,430
Others in their field
Top investigators on “Center For Translational Science Activities”
- Leonard Freedman · Leidos Biomedical Research, Inc.$236,002,771
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$135,625,793
- George R Seage · Abt Associates, Inc.$130,650,446
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$109,901,737
- Garret A Fitzgerald · University Of Pennsylvania$102,027,985
- Peter Gordon Gillespie · Oregon Health And Science University$94,827,254
Research focus
Center For Translational Science ActivitiesClinical SciencesResourcesResearch PersonnelTrainingTranslational ResearchResearch InfrastructureClinical ResearchCommunitiesInnovationCollaborationsScienceHealthcareFacultyUniversitiesDisciplineInstitutionFutureEnsureProgramsSuccessTraining And EducationCatalystMethodology
Grant awards (105)
Harvard Clinical and Translational Science Center$10,539,800
UM1 · FY2025 · TR · contact PI
Cancer Research and Training Coordination$480,831
P30 · FY2025 · CA · contact PI
Harvard Clinical and Translational Science Center$10,834,704
UM1 · FY2024 · TR · contact PI
Cancer Research and Training Coordination$578,513
P30 · FY2024 · CA · contact PI
Harvard Clinical and Translational Science Center$193,302
UM1 · FY2024 · TR · contact PI
Harvard Clinical and Translational Science Center$10,904,204
UM1 · FY2023 · TR · contact PI
Cancer Research and Training Coordination$600,917
P30 · FY2023 · CA · contact PI
The Harvard Clinical and Translational Science Center$12,867,348
UL1 · FY2022 · TR · contact PI
Cancer Research and Training Coordination$600,917
P30 · FY2022 · CA · contact PI
The Harvard Clinical and Translational Science Center$13,590,437
UL1 · FY2021 · TR · contact PI
SMART IRB, A NATIONAL SINGLE IRB RELIANCE PLATFORM TO SUPPORT MULTI-SITE HUMAN RESEARCH STUDIES$1,836,848
UL1 · FY2021 · TR · contact PI
The Harvard Clinical and Translational Science Center$246,756
UL1 · FY2021 · TR · contact PI
The Harvard Clinical and Translational Science Center$191,787
UL1 · FY2021 · TR · contact PI
The Harvard Clinical and Translational Science Center$18,987,654
UL1 · FY2020 · TR · contact PI
The Harvard Clinical and Translational Science Center$203,391
UL1 · FY2020 · TR · contact PI
The Harvard Clinical and Translational Science Center$20,847,870
UL1 · FY2019 · TR · contact PI
The Harvard Clinical and Translational Science Center$161,025
UL1 · FY2019 · TR · contact PI
The Harvard Clinical and Translational Science Center$20,101,860
UL1 · FY2018 · TR · contact PI
The Harvard Clinical and Translational Science Center$3,561,118
UL1 · FY2018 · TR · contact PI
The Harvard Clinical and Translational Science Center$406,800
UL1 · FY2018 · TR · contact PI
Harvard Clinical and Translational Science Center$24,600,001
UL1 · FY2017 · TR · contact PI
Harvard Clinical and Translational Science Center$2,055,255
KL2 · FY2017 · TR · contact PI
Harvard Clinical and Translational Science Center$630,616
TL1 · FY2017 · TR · contact PI
Harvard Clinical and Translational Science Center$21,886,759
UL1 · FY2016 · TR · contact PI
Harvard Clinical and Translational Science Center$3,303,230
UL1 · FY2016 · TR · contact PI
Harvard Clinical and Translational Science Center$1,752,000
KL2 · FY2016 · TR · contact PI
Harvard Clinical and Translational Science Center$624,064
TL1 · FY2016 · TR · contact PI
Harvard Clinical and Translational Science Center$129,250
UL1 · FY2016 · TR · contact PI
Harvard Clinical and Translational Science Center$21,911,939
UL1 · FY2015 · TR · contact PI
Harvard Clinical and Translational Science Center$1,799,620
KL2 · FY2015 · TR · contact PI
Harvard Clinical and Translational Science Center$544,880
TL1 · FY2015 · TR · contact PI
Harvard Clinical and Translational Science Center$21,900,459
UL1 · FY2014 · TR · contact PI
Harvard Clinical and Translational Science Center$1,738,300
KL2 · FY2014 · TR · contact PI
Harvard Clinical and Translational Science Center$611,464
TL1 · FY2014 · TR · contact PI
Harvard Clinical and Translational Science Center$74,902
UL1 · FY2014 · TR · contact PI
Harvard Clinical and Translational Science Center$12,405,924
UL1 · FY2013 · TR · contact PI
Harvard Clinical and Translational Science Center (UL1)$9,152,774
UL1 · FY2013 · TR · contact PI
Harvard Clinical and Translational Science Center$1,131,170
KL2 · FY2013 · TR · contact PI
Harvard Clinical and Translational Science Center$605,248
TL1 · FY2013 · TR · contact PI
Harvard Clinical and Translational Science Center (TL1)$215,408
TL1 · FY2013 · TR · contact PI
Harvard Clinical and Translational Science Center (KL2)$1
KL2 · FY2013 · TR · contact PI
Harvard Clinical and Translational Science Center (UL1)$22,215,738
UL1 · FY2012 · TR · contact PI
Harvard Clinical and Translational Science Center (KL2)$965,000
KL2 · FY2012 · TR · contact PI
Harvard Clinical and Translational Science Center (TL1)$515,648
TL1 · FY2012 · TR · contact PI
Harvard Clinical and Translational Science Center (UL1)$21,862,640
UL1 · FY2011 · RR · contact PI
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)$8,799,913
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$7,333,223
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$4,190,510
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,129,092
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$1,129,091
UL1 · FY2011 · RR · contact PI
Harvard Clinical and Translational Science Center (KL2)$965,000
KL2 · FY2011 · RR · contact PI
Harvard Clinical and Translational Science Center (TL1)$509,600
TL1 · FY2011 · RR · contact PI
Harvard Clinical and Translational Science Center (UL1)$333,331
UL1 · FY2011 · RR · contact PI
Harvard Clinical and Translational Science Center (UL1)$202,525
UL1 · FY2011 · RR · contact PI
Harvard Clinical and Translational Science Center (UL1)$183,333
UL1 · FY2011 · RR · contact PI
Harvard Clinical and Translational Science Center (UL1)$22,083,580
UL1 · FY2010 · RR · contact PI
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)$8,612,596
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$7,729,253
UL1 · FY2010 · RR · contact PI
Networking Research Resources Across America$7,371,476
U24 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$4,416,716
UL1 · FY2010 · RR · contact PI
Harvard Clinical and Translational Science Center (KL2)$964,897
KL2 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$662,508
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$662,507
UL1 · FY2010 · RR · contact PI
Harvard Clinical and Translational Science Center (TL1)$503,720
TL1 · FY2010 · RR · contact PI
Harvard Clinical and Translational Science Center (UL1)$21,826,106
UL1 · FY2009 · RR · contact PI
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)$11,024,366
UL1 · FY2009 · RR · contact PI
Networking Research Resources Across America$7,499,857
U24 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$7,420,221
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,119,970
UL1 · FY2009 · RR · contact PI
Harvard Clinical and Translational Science Center (UL1)$1,511,274
UL1 · FY2009 · RR · contact PI
Harvard Clinical and Translational Science Center (KL2)$1,222,370
KL2 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$630,775
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$630,774
UL1 · FY2009 · RR · contact PI
Harvard Clinical and Translational Science Center (UL1)$596,314
UL1 · FY2009 · RR · contact PI
Harvard Clinical and Translational Science Center (TL1)$500,864
TL1 · FY2009 · RR · contact PI
Harvard Clinical and Translational Science Center (UL1)$380,144
UL1 · FY2009 · RR · contact PI
Harvard Clinical and Translational Science Center (UL1)$285,090
UL1 · FY2009 · RR · contact PI
Harvard Clinical and Translational Science Center (UL1)$22,148,106
UL1 · FY2008 · RR · contact PI
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)$14,314,542
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$4,404,594
UL1 · FY2008 · RR · contact PI
Rebuilding Immunity for Survival$2,757,436
U19 · FY2008 · CA · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,642,712
UL1 · FY2008 · RR · contact PI
Harvard Clinical and Translational Science Center (KL2)$900,370
KL2 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$786,258
UL1 · FY2008 · RR · contact PI
Harvard Clinical and Translational Science Center (TL1)$498,008
TL1 · FY2008 · RR · contact PI
Specific Control of donor Anti-host Alloreactiviy$259,009
U19 · FY2008 · CA · contact PI
Administrative Core$123,728
U19 · FY2008 · CA · contact PI
Rebuilding Immunity for Survival$3,678,591
U19 · FY2007 · CA · contact PI
Rebuilding Immunity for Survival$3,835,265
U19 · FY2006 · CA · contact PI
Rebuilding Immunity for Survival$3,651,182
P01 · FY2005 · CA
Rebuilding Immunity for Survival$3,500,000
P01 · FY2003 · CA
ANTIGEN SPECIFIC IMMUNITY IN MULTIPLE MYELOMA$109,507
P01 · FY2002 · CA
TRANSLATIONAL THERAPEUTIC STRATEGIES IN ACUTE LYMPHOCYTIC LEUKEMIA$0
P01 · FY2002 · CA
T CELL IMMUNITY IN GERMINAL CENTER B CELL LYMPHOMA$0
P01 · FY2002 · CA
INDUCTION OF HOST-SPECIFIC TOLERANCE IN ALLOGENIC BMT$906,522
P01 · FY2001 · AI
ANTIGEN SPECIFIC IMMUNITY IN MULTIPLE MYELOMA$109,507
P01 · FY2001 · CA
T CELL IMMUNITY IN GERMINAL CENTER B CELL LYMPHOMA$0
P01 · FY2001 · CA
TRANSLATIONAL THERAPEUTIC STRATEGIES IN ACUTE LYMPHOCYTIC LEUKEMIA$0
P01 · FY2001 · CA
INDUCTION OF T CELL MEDIATED TUMOR SPECIFIC IMMUNITY AGAINST LEUKEMIA &LYMPHOMA$0
P01 · FY2001 · CA
MOLECULAR PATHWAYS REGULATING T CELL ANERGY TO ALLOANTIGEN$0
P01 · FY2001 · AI
INDUCTION OF HOST-SPECIFIC TOLERANCE IN ALLOGENIC BMT$880,116
P01 · FY2000 · AI
MOLECULAR PATHWAYS REGULATING T CELL ANERGY TO ALLOANTIGEN$276,356
P01 · FY2000 · AI
ANTIGEN SPECIFIC IMMUNITY IN MULTIPLE MYELOMA$275,287
P01 · FY2000 · CA
INDUCTION OF T CELL MEDIATED TUMOR SPECIFIC IMMUNITY AGAINST LEUKEMIA &LYMPHOMA$226,134
P01 · FY2000 · CA
TRANSLATIONAL THERAPEUTIC STRATEGIES IN ACUTE LYMPHOCYTIC LEUKEMIA$0
P01 · FY2000 · CA